Mannkind (MNKD) Long-Term Deferred Tax (2020 - 2025)

Mannkind (MNKD) reported Long-Term Deferred Tax of $41000.0 for Q4 2025, up 95.24% year-over-year from $21000.0 in Q4 2024, and up 95.24% quarter-over-quarter from $21000.0 in Q4 2024.

Mannkind (MNKD) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends

Mannkind (MNKD) has 4 years of Long-Term Deferred Tax data on file, last reported at $41000.0 in Q4 2025.

  • Long-Term Deferred Tax for Q4 2025 came in at $41000.0, up 95.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $41000.0 (up 95.24% YoY), and the FY2025 annual result was $41000.0, up 95.24% from the prior year.
  • Long-Term Deferred Tax rose to $41000.0 in Q4 2025 per MNKD's latest filing, from $21000.0 in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $41000.0 in Q4 2025 and troughed at $6000.0 in Q4 2023.
  • A 3-year average of $22666.7 and a median of $21000.0 in 2024 frame the typical range for Long-Term Deferred Tax.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax soared 250.0% in 2024, then surged 95.24% in 2025.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $6000.0 in 2023, then soared by 250.0% to $21000.0 in 2024, then surged by 95.24% to $41000.0 in 2025.
  • Business Quant data shows MNKD's Long-Term Deferred Tax at $41000.0 in Q4 2025, $21000.0 in Q4 2024, and $6000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 41,000.00
Dec 31, 2024 21,000.00
Dec 31, 2023 6,000.00
Sep 30, 2020 200,000.00